Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
Interv Neuroradiol. 2023 Jun;29(3):315-320. doi: 10.1177/15910199221087498. Epub 2022 Mar 23.
The utility of intravenous thrombolysis (IVT) prior to mechanical thrombectomy (MT) in large vessel occlusion stroke (LVO) is controversial. Some data suggest IVT increases MT technical difficulty. Within our hub-and-spoke telestroke network, we examined how spoke-administered IVT affected hub MT procedure time and pass number.
Patients presenting to 25 spoke hospitals who were transferred to the hub and underwent MT from 2018 to 2020 were identified from a prospectively maintained database. MT procedure time, fluoroscopy time, and pass number were obtained from operative reports.
Of 107 patients, 48 received IVT at spokes. Baseline characteristics and NIHSS were similar. The last known well (LKW)-to-puncture time was shorter among IVT patients (4.3 ± 1.9 h vs. 10.5 ± 6.5 h, p < 0.0001). In patients that received IVT, mean MT procedure time was decreased by 18.8 min (50.5 ± 29.4 vs. 69.3 ± 46.7 min, p = 0.02) and mean fluoroscopy time was decreased by 11.3 min (21.7 ± 15.8 vs. 33.0 ± 30.9 min, p = 0.03). Furthermore, IVT-treated patients required fewer MT passes (median 1 pass [IQR 1.0, 1.80] vs. 2 passes [1.0, 2.3], p = 0.0002) and were more likely to achieve reperfusion in ≤2 passes (81.3% vs. 59.3%, p = 0.01). An increased proportion of IVT-treated patients achieved TICI 2b-3 reperfusion after MT (93.9% vs. 83.8%, p = 0.045). There were no associations between MT procedural characteristics and LKW-to-puncture time.
Within our network, hub MT following spoke-administered IVT was faster, required fewer passes, and achieved improved reperfusion. This suggests spoke-administered IVT does not impair MT, but instead may enhance it.
静脉溶栓(IVT)在大血管闭塞性卒中(LVO)患者中进行机械取栓(MT)的效果存在争议。一些数据表明,IVT 会增加 MT 的技术难度。在我们的中枢-卫星远程卒中网络中,我们研究了卫星医院实施的 IVT 如何影响中枢医院 MT 手术时间和通过次数。
从一个前瞻性维护的数据库中确定了 2018 年至 2020 年期间在 25 个卫星医院就诊并转诊至中枢医院接受 MT 的患者。从手术报告中获得 MT 手术时间、透视时间和通过次数。
107 名患者中,48 名在卫星医院接受 IVT。基线特征和 NIHSS 相似。IVT 组的最后可获知的正常时间(LKW)至穿刺时间更短(4.3±1.9 h 比 10.5±6.5 h,p<0.0001)。在接受 IVT 的患者中,MT 手术时间平均减少 18.8 分钟(50.5±29.4 比 69.3±46.7 分钟,p=0.02),透视时间平均减少 11.3 分钟(21.7±15.8 比 33.0±30.9 分钟,p=0.03)。此外,IVT 治疗组患者需要的 MT 通过次数更少(中位数 1 次[IQR 1.0,1.80]比 2 次[1.0,2.3],p=0.0002),并且更有可能在 ≤2 次通过中实现再灌注(81.3%比 59.3%,p=0.01)。MT 后接受 IVT 治疗的患者中有更高比例达到 TICI 2b-3 再灌注(93.9%比 83.8%,p=0.045)。MT 手术特征与 LKW 至穿刺时间之间没有关联。
在我们的网络中,卫星医院实施 IVT 后,中枢医院的 MT 手术更快、需要的通过次数更少、并实现了更好的再灌注。这表明卫星医院实施 IVT 不会损害 MT,反而可能增强 MT。